Literature DB >> 10382759

Absolute requirement for the pre-T cell receptor alpha chain during NK1.1+ TCRalphabeta cell development.

G Eberl1, H J Fehling, H von Boehmer, H R MacDonald.   

Abstract

Most natural killer T (NKT) cells express a highly skewed alphabeta TCR repertoire, consisting of an invariant V alpha14-J alpha281 chain paired preferentially with a polyclonal Vbeta8.2 chain. This repertoire is positively selected by the monomorphic CD1d molecule expressed on cells of hematopoietic origin. The origin of NKT cells and their lineage relationship to conventional T cells is controversial. We show here that the development of NKT cells is absolutely dependent on expression of the pre-TCRalpha chain, in marked contrast to conventional T cells which arise in significant numbers even in the absence of a functional pre-TCR. Distinct developmental requirements for pre-TCR expression in the NKT and T cell lineages may reflect differences in the ability of the TCRalphabeta to substitute functionally for the pre-TCR in immature precursor cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382759     DOI: 10.1002/(SICI)1521-4141(199906)29:06<1966::AID-IMMU1966>3.0.CO;2-G

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 2.  Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.

Authors:  Shabbir Hussain; Melany Wagner; Dalam Ly; Terry L Delovitch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

Authors:  Joan O'Keeffe; Carol M Gately; Timothy Counihan; Michael Hennessy; Teresa Leahy; Anthony P Moran; Edward L Hogan
Journal:  J Neurol Sci       Date:  2008-08-15       Impact factor: 3.181

4.  CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells.

Authors:  Taehoon Chun; Michael J Page; Laurent Gapin; Jennifer L Matsuda; Honglin Xu; Hanh Nguyen; Hyung-Sik Kang; Aleksandar K Stanic; Sebastian Joyce; Walter A Koltun; Michael J Chorney; Mitchell Kronenberg; Chyung-Ru Wang
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

5.  Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.

Authors:  Roger B Voyle; Friedrich Beermann; Rosemary K Lees; Jens Schümann; Jacques Zimmer; Werner Held; H Robson MacDonald
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

6.  Characterization of the early stages of thymic NKT cell development.

Authors:  Kamel Benlagha; Datsen G Wei; Joel Veiga; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

7.  Early T cell receptor beta gene expression is regulated by the pre-T cell receptor-CD3 complex.

Authors:  I Aifantis; J Feinberg; H J Fehling; J P Di Santo; H von Boehmer
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

8.  The E delta enhancer controls the generation of CD4- CD8- alphabetaTCR-expressing T cells that can give rise to different lineages of alphabeta T cells.

Authors:  Iannis Aifantis; Craig H Bassing; Annette I Garbe; Katie Sawai; Frederick W Alt; Harald von Boehmer
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

9.  A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.

Authors:  Daniel G Pellicci; Kirsten J L Hammond; Adam P Uldrich; Alan G Baxter; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

10.  Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.

Authors:  Datsen G Wei; Shane A Curran; Paul B Savage; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.